Medicinal products shall include: active pharmaceutical ingredient (API); “in bulk” products; finished pharmaceutical products (medicinal preparations, drugs, medicaments); homoeopathic medicinal products; agents for detecting, as well as controlling pathogenic organisms or parasites; cosmetic products and medicinal supplements to food products; finished pharmaceutical products (medicinal preparations, drugs, medicaments) are dosed medicinal products in the form and state designed for use, which have undergone all stages of production (manufacturing), including final packaging; As part of finished pharmaceutical forms of medicinal products, they are used to cure, diagnose or prevent a disease, to change the condition, structures or physiological functions of the body, to care, treat and mitigate symptoms; excipient is any substance of a dosage form other than API or finished pharmaceutical product and, accordingly, does not exert a pharmacological, immunological or diagnostic action, is included as a compound in the medicinal product and is required for its production (manufacture), storage and/or use; narcotic medicinal products are medicinal products classified as narcotic in accordance with the legislation; poisonous medicinal products are medicinal products classified as poisonous by the central executive authority in charge of shaping the state policy in the field of health care; highly potent medicinal products are medicinal products classified as highly potent by the central executive authority in charge of shaping the state policy in the field of healthcare; radioactive medicinal products are medicinal products used in medical practice due to their properties to produce ionizing radiation; State Register of Medicinal Products of Ukraine is a regulatory document containing information on medicinal products approved for manufacture and use in medical practice; pharmacopoeial monograph is a regulatory technical document specifying the requirements for a medicinal product, its packaging, storage conditions, expiry date, and methods of quality control for medicinal products; State policy in the field of development, manufacturing, quality control and sale of medicinal products The state policy in the field of development, manufacturing, quality control and sale of medicinal products shall be focused on the support of scientific research, the development and implementation of new technologies, as well as the development of manufacturing highly efficient and safe medicinal products, meeting the demands of the population for medicinal products of proper quality and in the required range by maintaining the State Register of Medicinal Products of Ukraine with public access to it, implementation of relevant national programmes, priority financing, concessional loans, tax abatements, etc. The procedure for conducting a preclinical study of medicinal products, requirements for conditions of the separate studies, as well as the procedure for expert evaluation of materials for preclinical study of medicinal products shall be established by the central executive authority in charge of shaping the state policy in the field of healthcare with due regard to internationally accepted norms. To conduct clinical trials of medicinal products, the enterprises, institutions, organisations or citizens shall submit an appropriate application to the central executive authority implementing the state policy in the field of healthcare. The procedure for expert evaluation of materials pertinent to the clinical trials shall be established by the central executive authority in charge of shaping the state policy in the field of healthcare. Clinical trials of medicinal products involving a minor or a juvenile, the purpose of which is to optimise the dosage or administration schedule of the medicinal product for such individuals, shall be conducted after the completion of clinical trials of the relevant medicinal products involving full-aged legally competent individuals. The central executive authority implementing the state policy in the field of healthcare shall make a decision to terminate clinical trials or their separate phases in a threat to the patient's (volunteer's) health or life in connection therewith, as well as in the absence or insufficient its efficacy, or violations of ethical principles. The application for state registration of a medicinal product, registered by the competent authority of the United States of America, the Swiss Confederation, Japan, Australia, Canada, the centrally authorised medicinal product, registered by the competent authority of the European Union and used on the territory of these countries or European Union Member States, shall be accompanied by materials of registration dossier; materials on methods of quality control of medicinal product; a graphic image of the medicinal product package design and label text of the primary and secondary (if any) packages, written in language for labelling medicinal products under the requirements of this Law; instruction for medical use of the medicinal product, written in the language under the requirements of this Law; and a document confirming the registration fee payment. An applicant (holder of registration certificate) and/or his representative for implementation of a procedure for state registration of a medicinal product subject to procurement based on the results of a procurement procedure conducted by a specialised procurement organisation for implementation of a procurement agreement between the Ukrainian central executive authority in charge of shaping and implementing the state policy in the field of healthcare and the relevant specialised procurement organisation, as well as a medicinal product, registered by the competent authority of the United States of America, the Swiss Confederation, Japan, Australia, Canada, a centrally authorised medicinal product, registered by the competent authority of the European Union and used on the territory of these countries or European Union Member States, shall be a legal entity or an individual responsible for efficacy, safety and quality of medicinal product according to the procedure stipulated by the legislation and providing pharmacovigilance in Ukraine, as well as responsible for the accuracy and completeness of information contained in the materials attached to the application provided by this individual. During the review of registration materials for a medicinal product, registered by the competent authority of the United States of America, the Swiss Confederation, Japan, Australia, Canada, a centrally authorised medicinal product, registered by the competent authority of the European Union and used on the territory of these countries or European Union Member States, and the authenticity verification of registration materials for a medicinal product, subject to procurement based on the results of a procurement procedure conducted by a specialised procurement organisation for implementation of a procurement agreement between the Ukrainian central executive authority in charge of shaping and implementing the state policy in the field of healthcare and the relevant specialised procurement organisation, expert evaluation of the registration dossier materials submitted to the regulatory authority that registered this medicinal product shall not be performed. The following data on the medicinal product shall be entered into the State Register of Medicinal Products of Ukraine: name of medicinal product (trade name, international non-proprietary name); manufacturer (name, legal entity location and its manufacturing sites); data on registration of a medicinal product in the USA, the Swiss Confederation, Japan, Australia, Canada, as well as in the European Union Member States, if such a medicinal product has been passed the state registration as the medicinal product registered by the competent authority of the United States of America, the Swiss Confederation, Japan, Australia, Canada, a centrally authorised medicinal product, registered by the competent authority of the European Union to be used on the territory of these countries or European Union Member States, including name of the country of registration, registration authority and registration date; synonyms, chemical name, full composition of medicinal product; pharmacological action, pharmacotherapeutic group of medicinal product, indications, contraindications, precautions, interaction with other medicinal products; administration route; dose of active ingredient in each unit and quantity of units in a package; side effect, dosage form, storage conditions, expiry date, prescription status; instruction for medical use of medicinal product; pharmacopoeial monograph or methods of quality control of medicinal product; data on preliminary registration, The period specified in part twelve of this Article may be extended up to six years, if, during the first three years after the state registration of a reference/original medicinal product, the central executive authority implementing the state policy in the field of healthcare shall authorise to use it for one or more indications that are considered to have a particular advantage over the existing ones. For a medicinal product, registered by the competent authority of the United States of America, the Swiss Confederation, Japan, Australia, Canada, a centrally authorised medicinal product, registered by the competent authority of the European Union and used on the territory of these countries or European Union Member States, instead of the specified certified copy of the document confirming the compliance of the manufacturing conditions of a medicinal product submitted for registration with the medicinal product manufacturing requirements in Ukraine, a written obligation of the manufacturer to produce the relevant medicinal product for delivery to Ukraine at the same manufacturing sites used in the manufacturing of medicinal products intended to be used in the United States of America, the Swiss Confederation, Japan, Australia, Canada or the European Union Member States may be added. Medicinal products placed on the market during the period when the medicinal product has been authorised for use in Ukraine shall be allowed to be used in Ukraine until the end of their expiry date, determined by the manufacturer and indicated on the package. The grounds for refusing the state registration of a medicinal product, subject to procurement based on the results of a procurement procedure conducted by a specialised procurement organisation for implementation of a procurement agreement between the central executive authority in charge of shaping and implementing the state policy in the field of healthcare and the relevant specialised procurement organisation, shall be the failure to submit the relevant materials for such a medicinal product, determined by part five of this Article, or their submission in an incomplete volume, the identification of discrepancies in the submitted materials affecting the efficacy, safety and quality of such a medicinal product, the identification of inconsistencies in the name of manufacturer of such a medicinal product, its location and addresses of manufacturing sites indicated in the application for state registration, information by virtue of which this medicinal product is registered, the identification of non-authenticity of the translation of package label text of such a medicinal product or instruction for medical use of such a medicinal product. Peculiarities of state registration of medicinal products that may be procured by an individual authorised to conduct procurement in the field of healthcare If the state registration of a medicinal product is performed for procurement, which is carried out by an individual authorised to procure in the field of healthcare, such a medicinal product may be registered according to the state registration procedures specified in this Article. The state registration of a medicinal product, purchased by an individual authorised to procure in the field of healthcare and at the same time registered by the competent authority of the United States of America, the Swiss Confederation, Japan, Australia, Canada and used on the territory of these countries or by the competent authority of the European Union under the centralised procedure and used on the territory of the European Union Member States, shall be carried out with the following peculiarities (without restrictions on the possibility of state registration under the procedure specified in part five of this Article): an application for the state registration of such a medicinal product shall be accompanied by a document confirming the registration of the medicinal product in the relevant country or registration by the competent authority of the European Union under a centralised procedure and use on the territory of the European Union Member States as of the date of submission of the state registration application, signed by the applicant or their authorised representative; registration dossier materials; methods of quality control of the finished medicinal product (final product); a report on evaluation of this medicinal product by the regulatory authority of the country where the medicinal product is registered; an instruction for medical use of the medicinal product in the original language (in a language other than the state one); a summary of product characteristics in the original language (in a language other than the state one); a graphic image of the medicinal product package design and label text of the primary and secondary (if any) packages; translations of the label text of primary and secondary (if any) packages of the medicinal product and instruction for medical use, summary of product characteristics in the state language according to the structure and under the procedure determined by the central executive authority in charge of shaping and implementing the state policy in the field of healthcare signed by the applicant or his authorised representative; a certified copy of the document confirming The state registration of a medicinal product purchased by an individual authorised to make procurements in the field of healthcare, regardless of the manufacturer's country, shall be conducted with the following peculiarities: at the applicant's request, the state registration of such a medicinal product may be conducted with labelling and instruction for medical use of the medicinal product that meet the requirements of parts one, two, three and five of Article 12 of this Law, or with labelling, instruction for medical use of the medicinal product and summary of product characteristics in the original language (in a language other than the state one); if the state registration of a medicinal product is conducted with labelling and instruction for medical use of the medicinal product that meet the requirements of parts one, two, three and five of Article 12 of this Law, the application for state registration of such a medicinal product shall be accompanied by registration dossier materials; materials on methods of the medicinal product quality control; a document confirming the payment of registration fee; labelling of primary and secondary (if any) packages of the medicinal product; instruction for medical use of the medicinal product; a certified copy of the document confirming the compliance of manufacturing conditions of the medicinal product submitted for registration with the medicinal product manufacturing requirements in Ukraine, issued by the central executive authority The period for an expert work shall not include the time when the materials have been finalised by the applicant, the time required for receiving answers from the third parties (including from the authorised bodies of Ukraine and/or other countries) related to the expert evaluation, as well as the time for laboratory tests; the decision to approve or refuse the registration of such a medicinal product shall be made by the central executive authority in charge of shaping and implementing the state policy in the field of healthcare based on the results of an expert evaluation of the registration materials for such a medicinal product within a period not exceeding five working days; the decision to refuse the state registration of such a medicinal product shall be made if the opinions on its efficacy and safety are not confirmed, as well as in discrepancies of translations of the label text of the medicinal product packaging, instruction for medical use of the medicinal product or summary of product characteristics. In addition to information provided for in part ten of Article 9 of this Law, the State Register of Medicinal Products of Ukraine on medicinal products registered according to part four of this Article and on medicinal products registered according to part five of this Article with labelling, instruction for medical use and summary of product characteristics in the original language (a language other than the state one) shall include data on the belonging of a medicinal product to medicinal products that may be in circulation on the territory of Ukraine solely for free supply to the structural health care subdivisions of Oblast State Administrations, Kyiv and Sevastopol City State Administrations or business entities, licensed to conduct business activities in medical practice, based on the results of procurements using the state budget funds, conducted by an individual authorised to make procurements in the field of healthcare, for the implementation of programmes and centralised health protection measures. In connection with spreading the coronavirus disease (COVID-19) pandemic to ensure the possibility of emergency medical use of vaccines or other medical immunobiological preparations for the specific prevention of coronavirus disease (COVID-19) according to the procedure for state registration under the obligation established by the Cabinet of Ministers of Ukraine, such vaccines or others medical immunobiological preparations may be subject to accelerated state registration if the central executive authority in charge of shaping and implementing the state policy in the field of healthcare decides to approve the state registration of vaccines or other medical immunobiological preparations for emergency medical use, taking into account certain obligations, if the applicant can prove the absence of the possibility to provide full data on the efficacy and safety of vaccines or other medical immunobiological preparations under the normal conditions of use for objective reasons and if: 1) the available data on the successful preclinical studies/trials, separate phases of clinical trials/studies and the obtained results together contain scientifically substantiated evidence, including data from adequate and well-controlled studies, that suggests that vaccines or other medical immunobiological preparations may be effective for the coronavirus disease (COVID-19) prevention; 2) an emergency use authorisation is granted by the competent authority of the United States of America, the United Kingdom, the Swiss Confederation, Japan, Australia, Canada, In circumstances specified in part one of this Article, vaccines or other medical immunobiological preparations for the prevention of coronavirus disease (COVID-19) may be registered for emergency medical use for a period that will allow fulfilling the following obligations: the applicant shall be liable to provide information on the completed clinical trials, including their results, within a period agreed with the central executive authority in charge of shaping and implementing the state policy in the field of healthcare, which constitute grounds for a risk-benefit expert evaluation; vaccines or other medical immunobiological preparations submitted for state registration under the obligation for emergency medical use shall be available only on the health care provider's prescription and, in certain cases, used only under the strict medical supervision, including in the health care facilities; it shall be indicated in a summary of characteristics of the vaccines or other medicinal immunobiological preparations, instruction for medical use and/or package insert that the available characteristics of this medicinal product are insufficient. Following the decision to issue a registration certificate for vaccines or other medical immunobiological preparations, the central executive authority in charge of shaping and implementing the state policy in the field of healthcare may obligate the holder of the registration certificate for such vaccines or other medical immunobiological preparations to: 1) conduct post-authorisation safety studies in the presence of risks related to vaccines or other medical immunobiological preparations registered for emergency medical use. If the competent authority of the United States of America, the United Kingdom, the Swiss Confederation, Japan, Australia, Canada, the People's Republic of China, India or under a centralised procedure the competent authority of the European Union, according to the national legislation of the country granting the authorisation or the European Union, is granted the authorisation for the emergency use of a vaccine or other medical immunobiological preparation, or a vaccine or other medical immunobiological preparation is registered by such competent authority under a certain condition or is granted the WHO prequalification, such a vaccine or other medical immunobiological preparation may be provided with accelerated registration in Ukraine for emergency medical use under the procedure established by the Cabinet of Ministers of Ukraine, taking into account the following peculiarities: 1) an application for state registration for emergency medical use shall be accompanied solely by a document confirming the decision to grant an authorisation for emergency use or registration under a certain condition in the relevant country or registration under a certain condition by the competent authority of the European Union (or another essentially identical decision under the applicable laws of the United States of America, the United Kingdom, the Swiss Confederation, Japan, Australia, Canada, the People's Republic of China, India or under a centralised procedure by the competent authority of the European Union according to the national legislation of the country granting the authorisation or the European Union) on the date of submission of an application for state registration for emergency medical use, signed by the applicant or his authorised representative; a vaccine or other medical immunobiological preparation evaluation report drawn up by the regulatory authority of the country in which the vaccine or other medical immunobiological preparation is registered (if any, if such a document is provided for under the relevant country legislation, in the absence of such a document, a relevant note shall be made in the application for state registration for emergency medical use); a document on risk assessment and management approved by a decision on granting an authorisation for emergency use or on registration under a certain condition in the relevant country or registration under a certain condition by the competent authority of the European Union (if any, if such a document During the authenticity verification of registration materials, an expert evaluation of the registration dossier materials submitted to the regulatory authority that registered the vaccine or other medical immunobiological preparations shall not be performed; 3) the decision to approve or refuse the registration for emergency medical use of such a vaccine or other medical immunobiological preparation for emergency medical use shall be made by the central executive authority in charge of shaping and implementing the state policy in the field of healthcare, based on the results of the authenticity verification of registration materials within a period not exceeding three working days; 4) the grounds for refusing the state registration for emergency medical use may be solely the failure to submit the relevant materials provided for in this part of the Article or incomplete set of the submitted materials, or the detection of discrepancies in the submitted materials affecting the efficacy, safety and quality of a vaccine or other medical immunobiological preparations, or the detection of non-authenticity of translations of the label text(s) of the package(s), instruction for medical use or summary of product characteristics; 5) amendments to the registration materials shall be made under the procedure established by the central executive authority in charge of shaping and implementing the state policy in the field of healthcare by virtue of a decision taken by the same competent authority of the United States of America, the After the state registration of vaccines or other medical immunobiological preparations for the specific prevention of coronavirus disease (COVID-19) under the obligation for emergency medical use, the central executive authority in charge of shaping and implementing the state policy in the field of healthcare, by the decision of the Cabinet of Ministers of Ukraine, has the right to take obligations on behalf of Ukraine related to the procurement, use of vaccines or other medical immunobiological preparations for the specific prevention of coronavirus disease (COVID-19), the state registration of which has been conducted according to the requirements of this Article, including the waiver of sovereign immunity in regard to such obligations, as well as release of liability of the manufacturer and/or the registration certificate holder, including their employees, medical personnel, if the use of such vaccines or other medical immunobiological preparations was conducted according to the instructions approved by the central executive authority in charge of shaping and implementing the state policy in the field of healthcare and other individuals involved in the implementation of measures related to vaccination, for any consequences caused by the use of such vaccines or other medical immunobiological preparations for the specific prevention of coronavirus disease (COVID-19). Labelling of medicinal products The label, outer and immediate packages of the medicinal product shall contain the following data: name of the medicinal product; name and address of its manufacturer; registration number; batch number; administration routes; a dose of an active ingredient in each unit and their quantity supplied in a package; expiry date; storage conditions; precautions. Each medicinal product sold shall be accompanied by instruction for medical use of the medicinal product, which shall contain: name of the medicinal product; general characteristics (chemical name, basic physical and chemical properties, composition); data on pharmacological properties; indications for use; contraindication; interaction with other medicinal products; administration routes and dosage; side effects; precautions; dosage forms; conditions of storage and expiry date; prescription status. In the case of import into the territory of Ukraine of an unregistered medicinal product for supply based on the results of procurements conducted by an individual authorised to make procurements in the field of healthcare for the implementation of programmes and centralised health protection measures, or a procurement conducted by an individual authorised to make procurements in the field of healthcare using the local budget funds according to the provisions of Article 17 of this Law, labelling, as well as instruction for medical use/summary of characteristics of such a medicinal product may be in the original language (a language other than the state one) given that the supplier provides each package of the medicinal product imported into the territory of Ukraine with a copy, approved by the central executive authority in charge of shaping and implementing the state policy in the field of healthcare, translations of the label text and instruction for medical use / summary of product characteristics in the state language and a notice issued by the central executive authority in charge of shaping and implementing the state policy in the field of healthcare according to the procedure established by the law. Powers of officials of the central executive authority implementing the state policy in the field of control over the quality and safety of medicinal products The officials of the central executive authority implementing the state policy in the field of control over the quality and safety of medicinal products within the scope of their competence established by the legislation shall have the right to: A procedure for sampling of medicinal products shall be determined by the Cabinet of Ministers of Ukraine; give binding instructions to remedy violations of standards and technical conditions, pharmacopoeial articles and technological regulations, as well as to remedy violations in the process of manufacturing, storage, transportation, and sale of medicinal products; transfer inspection materials containing signs of a criminal offence to the pre-trial investigation bodies; impose fines on business entities, regardless of their ownership, in case of violation of standards and technical conditions, pharmacopoeial articles and technological regulations in the process of manufacturing, storage, transportation and sale of medicinal products; draw up protocols on administrative offences and examine cases of administrative offences as provided for by the law; make decisions according to the established procedure on withdrawal from the circulation and prohibition (suspension) of manufacturing, sale and use of medicinal products nonconforming the regulatory acts and regulatory documents, as well as imported into the territory of Ukraine or exported from the territory of Ukraine in violation of the procedure established by the law. Legal protection of officials of the central executive authority implementing the state policy in the field of control over the quality and safety of medicinal products Officials of the central executive authority implementing the state policy in the field of control over the quality and safety of medicinal products shall be protected by the law. The compliance of the material and technical resources, qualification of personnel, as well as conditions for the quality control of medicinal products to be imported into the territory of Ukraine with the applicable requirements and characteristics stated in the documents submitted by the applicant for obtaining the licence shall be subject to mandatory verification before issuing the licence within the time limits, provided for licensing, at the place of activity of the licensing authority according to the procedure established by the central executive authority in the field of healthcare. It shall be allowed to import into the territory of Ukraine medicinal products registered in Ukraine that are subject to procurement based on the results of a procurement procedure conducted by a specialised procurement organisation only for the implementation of a procurement agreement between the central executive authority in charge of shaping and implementing the state policy in the field of healthcare and the relevant specialised procurement organisation in the presence of a batch quality certificate, which is issued by the manufacturer. individual use by citizens; supply based on the results of procurements conducted by an individual authorised to make procurements in the field of healthcare for the implementation of programmes and centralised health protection measures using the state budget funds or procurement conducted by an individual authorised to make procurements in the field of healthcare using the local budget funds, provided that the following set of circumstances shall be present: there are no alternative medicinal products for the prevention and/or treatment of the relevant diseases in Ukraine (there are no medicinal products registered in Ukraine with the relevant active substance); Additionally, by a separate decision of the central executive body implementing the state policy in the field of healthcare, it shall be allowed to import medicinal products from foreign countries that are not registered in Ukraine for the purpose of medical supplies (medical use) for military personnel, rank and file and commanding officers, and other individuals, who, according to the law, are sent by Ukraine to participate in an international peacekeeping operation as part of a national contingent or national personnel, perform tasks during the anti-terrorist operation, the Joint Forces Operation, to implement the measures ensuring the national security and defence, counteract and suppress the armed aggression of the Russian Federation in Donetsk and Luhansk Oblasts, during a state of emergency, a special period, subject to availability of the documents confirming the registration and use of medicinal products in such countries. Unregistered medicinal products that may be imported into the territory of Ukraine for the purpose of supply based on the results of procurements conducted by an individual authorised to make procurements in the field of healthcare for the implementation of programmes and centralised health protection measures using the state budget funds, or procurement conducted by an individual authorised to make procurements in the field of healthcare using the local budget funds, shall be supplied free of charge to the structural health care subdivisions of Oblast State Administrations, Kyiv and Sevastopol City State Administrations or to business entities, licensed to carry out business activities in medical practice. The list of unregistered medicinal products (according to the international non-proprietary names) that may be imported into the territory of Ukraine for the purpose of supply based on the results of procurements conducted by an individual authorised to make procurements in the field of healthcare for the implementation of programmes and centralised health protection measures using the state budget funds, or procurement conducted by an individual authorised to make procurements in the field of healthcare using the local budget funds, and the procedure for forming such a list shall be approved by the Cabinet of Ministers of Ukraine. The List of Business Entities Entitled to Conduct Electronic Retailing of Medicinal Products is maintained according to the procedure approved by the central executive authority in charge of shaping and implementing the state policy in the field of healthcare; the website of the business entity entitled to conduct electronic retailing of medicinal products shall contain information on the contact details of the licensing authority, the state authorities for control over the medicinal product quality; the logo with a hypertext link displayed on each website page and routed the consumer to the page of the List of Business Entities Entitled to Conduct Electronic Retailing of Medicinal Products (such a logo is used solely by the pharmacies included in the List of Business Entities Entitled to Conduct Electronic Retailing of Medicinal Products); an option of providing a pharmacist's consultation (if necessary) when ordering a medicinal product through the pharmacy's website; the delivery cost of a medicinal product. If other business entities are involved in the delivery of medicinal products to the final consumer, the essential conditions of the agreement on such delivery shall be as follows: the availability of the equipment and supply ensuring compliance with the medicinal product storage conditions determined by the manufacturer during their delivery in business entities that are involved in the medicinal product delivery to the final consumer and the obligations to comply with these requirements; a provision on the possibility of monitoring of the compliance with the storage conditions of medicinal products during their delivery by a business entity conducted electronic retailing of medicinal products – at least once a year and by the state control authorities over the medicinal product quality – as part of the implementation of measures of the state quality control of medicinal products; the rights and obligations of the parties; the liability of the parties (subject to the provisions defined in this Article); the contract duration. Information on the legislation on electronic retailing of medicinal products, the logo of business entities entitled to conduct electronic retailing of medicinal products, the List of Business Entities Entitled to Conduct Electronic Retailing of Medicinal Products, and their website addresses, as well as information on the risks associated with medicinal products, retail electronic trade of which is illegal, shall be posted on the official website of the licensing authority. In the absence of a licence to conduct business activities on the wholesale trade in medicinal products in an individual authorised to make procurements in the field of healthcare, compliance with the legal requirements to license business activities during storage, transportation of medicinal products purchased by an individual authorised to make procurements in the field of healthcare, the legislation on the quality control of medicinal products during wholesale trade shall be ensured by engaging the business entities licensed to conduct business activities on the wholesale trade in medicinal products in compliance with the legislation in the field of public procurements. The rules for prescribing medicinal products, as well as the list of medicinal products that may be sold without a doctor's prescription, shall be approved by the central executive authority in charge of shaping the state policy in the field of healthcare. Logistic support The State shall organise the logistic support for the development, manufacturing, quality control and sale of medicinal products to the extent required for providing the population with a guaranteed level of medical services. Information support The state shall establish conditions for information support in the field of development, manufacturing, quality control and sale of medicinal products in Ukraine. The central executive authority implementing the state policy in the field of healthcare shall inform the population about the medicinal products registered and deleted from the State Register of Medicinal products of Ukraine. The criteria used to determine the drugs, the advertising of which is prohibited, shall be approved by the central executive authority in charge of shaping the state policy in the field of healthcare according to the requirements of the law. International co-operation Ukraine shall participate in international co-operation in the field of development, manufacturing, quality control, and sale of medicinal products.